Ligand · VFB
VFB · 3,4-dihydro[1,2,4]triazolo[1,5-a][3,1]benzimidazol-9-ium
VFB, 3,4-dihydro[1,2,4]triazolo[1,5-a][3,1]benzimidazol-9-ium (C8 H7 N4 +1, 159.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds…
- Component
- VFB
- Formula
- C8 H7 N4 +1
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
VFB in 2 structures; the first of them:
- 4BDA · Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase… · VFB A1515 · binds LEU226, GLY227, VAL234, ALA247, ILE286, LEU301, GLU302, LEU303 and 4 more
- 4BDA · Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase… · VFB A1515 · binds LEU226, GLY227, VAL234, ALA247, ILE286, LEU301, GLU302, LEU303 and 4 more
Residues it binds most
LEU 2, GLU 2, GLY 2, ALA 2, ILE 2, MET 2, VAL 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.